Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free. Do not exceed recommended dose. Monitor for increased need; if inadequate control, reevaluate and ...
The U.S. Food and Drug Administration recently issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane or HFA-propelled albuterol ...
Last warning: Asthma inhalers go "green" on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch. The medicine inside these rescue inhalers — the ...
Time is running out for patients who use albuterol inhalers to replace those propelled by chlorofluorocarbons (CFCs) with ones that rely on eco-friendly hydrofluoroalkane (HFA). After December 31, ...
Co confirms that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sepracor Inc. in connection with its Xopenex 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL. On July ...
BOSTON, May 18 (Reuters) - Medicare plans to cut reimbursement levels for Sepracor Inc.'s asthma drug Xopenex to the level of a generic rival, according to Jon LeCroy, an analyst at Natexis ...
Marlborough-based Sepracor Inc. announced that it has settled a patent dispute over its Xopenex brand asthma inhaler with Teva Pharmaceuticals USA Inc. and Barr Laboratories. Under the agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results